News Telehealth Triumph: Hims & Hers Resurfaces in the Weight Loss Arena, Shares Skyrocket Hims & Hers Health enters the weight loss drug market, boosting shares over 5% with the introduction of Eli Lilly’s tirzepatide and by Mathew Quive 1 month ago
The Breakthrough You’ve Been Waiting For: Karyopharm’s New Hope for Myelofibrosis Patients 21 hours ago
Kelly Ripa en Mark Consuelos: De Toekomst van AI-gedreven Verhalen. Hoe Dit Power Koppel het Podium Neemt February 13, 2025